99. Comparison of Procalcitonin Testing to a Targeted Audit-and Feedback Strategy on Prescribed Durations of Therapy for Community-Acquired Pneumonia

BACKGROUND: The procalcitonin (PCT) assay is FDA-approved to help guide antimicrobial treatment of respiratory tract infections, however, conflicting data exist regarding its impact on shortening durations of therapy. The purpose of this study was to compare the impact of PCT to a targeted audit-and...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Lauren, Dumkow, Lisa E, Buss, Paige, Beuschel, Thomas, Jameson, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777561/
http://dx.doi.org/10.1093/ofid/ofaa439.144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777561/
http://dx.doi.org/10.1093/ofid/ofaa439.144

Ejemplares similares